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The treatment of tuberculosis presents
an enormous challenge to global health.
Tuberculosis is a leading cause of death
from infectious diseases worldwide, sec-
ond only to the human immunodeficiency
virus (HIV). Although several therapeutics
and vaccines are available to treat and pre-
vent tuberculosis infections, more virulent
varieties of tuberculosis and increased drug
resistance in the form of multi, extreme,
and total drug resistant disease are major
emergent threats. Mycobacterium tubercu-
losis is an obligate human pathogen and
has co-evolved with humans for millen-
nia, thus it has influenced the immune
system of individuals who live in tubercu-
losis endemic regions. It is essential that
therapeutic and research strategies tar-
geted at tuberculosis should reflect this
co-evolution. Elucidating the basic biol-
ogy and immunology of tuberculosis is
relevant to increasing and consolidating
our fundamental understanding of the dis-
ease; thus, facilitating the development of
therapeutics that will eradicate the disease
and enable the immune system to achieve
protection from tuberculosis.
The book, The New Paradigm of Immu-
nity to Tuberculosis edited by Maziar
Divangahi (1), seeks to address the need
for a comprehensive understanding of
the immunological processes underly-
ing tuberculosis infection by combining
immunological and research perspectives.
There are several comprehensive reviews
and textbooks about immunity to tubercu-
losis infection, particularly concentrating
on genetic susceptibilities (2) and thera-
peutics (3). However, the unique contri-
bution of this book is that it is the most
contemporary resource, which draws on
the expertise of 25 distinguished interna-
tional specialists to provide a single author-
itative book on the induction and main-
tenance of immunity against tuberculosis
infection.
THE CHALLENGE OF IMMUNITY TO
TUBERCULOSIS
Infection by Mycobacterium tuberculosis is
characterized by infiltration of alveolar
macrophages, which is explored extensively
within the book. By altering the intracellu-
lar environment of alveolar macrophages,
the pathogen is able to replicate successfully
within the inhospitable cellular environ-
ment. Mycobacterium tuberculosis is able
to inhibit the induction of apoptotic path-
ways and autophagy within macrophages
whilst initiating necrosis in order to evade
host defenses and prevent the launch of
an immune response against the pathogen.
This presents a potential therapeutic target
to induce immunity to tuberculosis infec-
tion. The book also discusses lipid medi-
ators of pro-apoptotic and pro-necrotic
pathways within macrophages, thus high-
lighting and delineating the importance
of these pathways in ultimately deter-
mining whether successful immunity is
stimulated against Mycobacterium tubercu-
losis infection or if clinical disease devel-
ops. Interestingly, alveolar macrophages
are also target cells for HIV infection.
The book discusses HIV and tuberculo-
sis co-infection in several chapters, thus
highlighting the importance of their rela-
tionship. The burden of HIV infection
on host immune function substantially
increases the risk of Mycobacterium tuber-
culosis infection and its progression to
active disease; therefore, understanding the
complex association between both infec-
tions is important for successfully tackling
tuberculosis.
The induction of immunity to tuber-
culosis infection is mediated via CD4+
effector T cells and CD8+ T cells, which
are discussed to a great extent within the
book. Recently, there has been interest in
the ability of γδ T cells to restrain tuber-
culosis infection as well (4). The book
touches on this briefly; however, with fas-
cinating developments occurring in this
field, it would be interesting if it were
expanded into a separate chapter. A par-
ticularly distinctive aspect to this book is
that it discusses the relationship between
regulatory T cells (Treg) and tuberculo-
sis infection. Treg may play a role in
limiting inflammation-mediated damage
during infection; however, the book also
notes that the induction of immunity to
tuberculosis and infection clearance also
expands CD4+ regulatory T cell (Treg)
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populations that express the transcription
factor FOXP3. This is discussed in further
detail in a chapter by Ryan P. Larson and
Shahin Shafiani (5). Treg inhibit inflamma-
tory processes and reduce the potency of
effector responses to infection. Thus, Lar-
son and Shafiani hypothesize that Mycobac-
terium tuberculosis is capable of hijacking
Treg biology and promoting their expan-
sion in order to serve the needs of the
bacterium and avoid detection by the adap-
tive immune response. Very little is known
about the mechanism by which Mycobac-
terium tuberculosis expands Treg; however,
this could be a potential therapeutic target
for improved management of tuberculosis.
By inhibiting the factors that promote Treg
expansion, potent effector responses can
then be initiated by the adaptive immune
response to clear infections. Interestingly,
regulatory ability within the T cell pop-
ulation is not confined solely to CD4+
T cells. It has been shown that CD8+
T cells can also induce FOXP3 expres-
sion and become tolerogenic after anti-
genic stimulation (6). Therefore, it would
be intriguing if further research will iden-
tify a relationship between CD8+ Treg and
tuberculosis infection, and determine if
these cells contribute to the pathogenesis
of disease.
STRATEGIES TO INVESTIGATE AND
INDUCE IMMUNITY
Understanding host and bacterial path-
ways involved in tuberculosis infection is
essential for identifying novel measures for
combating infection. The book explores
tuberculosis research involving zebra fish
and granuloma formation by an infected
host. Granulomas are organized aggre-
gates of mature macrophages, which are
critical for host immunity to tubercu-
losis infection. The book also exam-
ines the very important field of vaccina-
tion research and immunization strate-
gies against tuberculosis. Effective vac-
cination is essential for restraining the
spread of Mycobacterium tuberculosis infec-
tion and underlies effective immunity
against the pathogen. This book is
exceptional in that it combines knowl-
edge on the mechanism of induction of
humoral immunity to tuberculosis with
recent research developments, which take
into account the route of immunization
to enhance vaccine-elicited immunity. A
greater understanding of these processes,
which improve the efficacy of vaccines
and thus boost immunity to infection, will
be very important in limiting the global
spread of Mycobacterium tuberculosis
infection.
In conclusion, Divangahi has edited an
excellent and comprehensive book that
brings together the expertise of eminent
specialists within the field of immunity to
tuberculosis. The book explores the epi-
demiology and biology of Mycobacterium
tuberculosis infection, whilst investigating
therapeutic applications and immuniza-
tion strategies that may contribute sig-
nificantly to reduce the global burden of
disease.
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